F. del Valle

662 total citations
8 papers, 308 citations indexed

About

F. del Valle is a scholar working on Oncology, Hematology and Infectious Diseases. According to data from OpenAlex, F. del Valle has authored 8 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Hematology and 1 paper in Infectious Diseases. Recurrent topics in F. del Valle's work include Acute Myeloid Leukemia Research (5 papers), Neutropenia and Cancer Infections (4 papers) and Hematopoietic Stem Cell Transplantation (2 papers). F. del Valle is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Neutropenia and Cancer Infections (4 papers) and Hematopoietic Stem Cell Transplantation (2 papers). F. del Valle collaborates with scholars based in Germany, Austria and Switzerland. F. del Valle's co-authors include J. Th. Fischer, Konstanze Döhner, Stefan Fröhling, Frank Hartmann, Hartmut Döhner, Axel Benner, Richard F. Schlenk, Sabine Käyser, Marianne Habdank and A Corbacioglu and has published in prestigious journals such as Cancer, Leukemia and Haematologica.

In The Last Decade

F. del Valle

8 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. del Valle Germany	6	261	145	102	61	58	8	308
J. Th. Fischer Germany	6	298 1.1×	157 1.1×	101 1.0×	36 0.6×	67 1.2×	10	332
S. Brunet Mauri United Kingdom	3	275 1.1×	96 0.7×	79 0.8×	50 0.8×	62 1.1×	5	312
RR Ellison United States	5	246 0.9×	164 1.1×	140 1.4×	52 0.9×	66 1.1×	6	339
Salvatore Mirto Italy	12	353 1.4×	123 0.8×	145 1.4×	77 1.3×	114 2.0×	28	405
P Antunović Sweden	6	295 1.1×	258 1.8×	83 0.8×	22 0.4×	35 0.6×	9	338
M Edelstein United States	5	436 1.7×	130 0.9×	133 1.3×	117 1.9×	87 1.5×	8	469
Jinsong Jia China	12	280 1.1×	91 0.6×	90 0.9×	67 1.1×	75 1.3×	39	321
M. C. Sauerland Germany	4	224 0.9×	123 0.8×	72 0.7×	17 0.3×	66 1.1×	7	242
Raffaella Grasso Italy	8	181 0.7×	111 0.8×	87 0.9×	34 0.6×	34 0.6×	22	235
Fengkuan Yu China	7	222 0.9×	104 0.7×	73 0.7×	32 0.5×	67 1.2×	25	265

Countries citing papers authored by F. del Valle

Since Specialization

Citations

This map shows the geographic impact of F. del Valle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. del Valle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. del Valle more than expected).

Fields of papers citing papers by F. del Valle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. del Valle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. del Valle. The network helps show where F. del Valle may publish in the future.

Co-authorship network of co-authors of F. del Valle

This figure shows the co-authorship network connecting the top 25 collaborators of F. del Valle. A scholar is included among the top collaborators of F. del Valle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. del Valle. F. del Valle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Schlenk, Richard F., Konstanze Döhner, Michael Kneba, et al.. (2008). Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B. Haematologica. 94(1). 54–60. 144 indexed citations

2.

Schlenk, Richard F., Axel Benner, Frank Hartmann, et al.. (2003). Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial. Leukemia. 17(8). 1521–1528. 87 indexed citations

3.

Kröger, Nicolaus, Tatjana Zabelina, William Krüger, et al.. (2000). Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia. Bone Marrow Transplantation. 26(7). 711–716. 21 indexed citations

4.

Metzner, Bernd, Rebecca Dirks, Wolfgang Gebauer, et al.. (1999). Early Infectious Complications after High-Dose Therapy and Autologous Blood Stem Cell Transplantation. Oncology Research and Treatment. 22(6). 491–496. 4 indexed citations

5.

Nuessler, V., R. Pelka‐Fleischer, F. del Valle, et al.. (1997). Expression and functional activity of P-glycoprotein in adult acute myelogenous leukemia patients. Annals of Hematology. 75(1-2). 17–26. 15 indexed citations

6.

Valle, F. del, et al.. (1994). The endoscopic diagnosis of the invaginating ampulla of Vater mimicking choledocholithiasis.. PubMed. 89(1). 126–7. 1 indexed citations

7.

Haas, Rainer, F. del Valle, J.-Th. Fischer, et al.. (1993). Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia.. PubMed. 20(6 Suppl 8). 20–6. 7 indexed citations

8.

Ho, Anthony D., F. del Valle, M. Engelhard, et al.. (1990). Mitoxantrone/high-dose ara-c and recombinant human gm-csf in the treatment of refractory non-hodgkin's lymphoma a pilot study. Cancer. 66(3). 423–430. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact